Technology Transfer

Annual Technology Showcase to Spotlight Collaboration Opportunities with NCI and FNL

The National Cancer Institute and Frederick National Laboratory for Cancer Research will hold the annual Technology Showcase on Wednesday, Sept. 7 in a hybrid format to welcome in-person attendees as well as remote participants from around the United States and the world. The event is scheduled from noon to 5:30 pm ET at the FNL’s Advanced Technology Research Facility in Frederick, Md.

Technology Transfer Managers Are Here to Make Agreements and Patents Painless

NCI and Frederick National Laboratory investigators make important scientific discoveries every day. Sometimes those discoveries lead to an invention. While competitive science can make it tempting to report the findings right away, that might not be the best idea. Instead, it’s time to talk with a technology transfer manager.

Translate Science from Bench to Market with NCI's Technology Transfer Ambassadors Program

There are times where opportunities are not present in our environment, so sometimes it’s necessary to make them. Like the famous paleoanthropologist Donald Johanson said, “one must take initiative in life to achieve what he or she wants.” That is exactly what Laura Prestia, Ph.D., and her colleagues, Robert Sons, Ph.D., and Alan Alfano, Ph.D., did in 2016 when they started the Technology Transfer Ambassadors Program (TTAP).

2021 Technology Showcase Returns with a New Focus on the Patient’s Voice

Block off the afternoon of September 1, 2021, in your calendar because the Technology Showcase is returning for its fifth year. The event will be fully virtual and, as always, feature exciting biomedical technologies, panels on important topics for industry stakeholders, and various poster pitches. New this year is an increased focus on the patient’s voice.

Update: Team Responsible for the Technology Showcase Receives NCI Director’s Award and 2021 FLC Award

The Federal Laboratory Consortium for Technology Transfer recently awarded the Frederick National Laboratory and National Cancer Institute Technology Showcase a 2021 State and Local Economic Development Award. The FLC is a nationwide network of more than 300 federal laboratories, agencies, and research centers that promotes federal technology transfer.

2020 Technology Showcase brings NCI and FNL technologies to a new audience

The 2020 Technology Showcase welcomed more than 300 viewers for half a day of presentations and panels on technology commercialization and collaboration. The annual event once again highlighted the capabilities of the Frederick National Laboratory for Cancer Research, National Cancer Institute, and greater Frederick region—but this year, with its novel virtual format, it reached new audiences.

Team Responsible for the Technology Showcase Receives NCI Director’s Award

A broadly based team from Frederick National Laboratory, NCI’s Technology Transfer Center, and NCI’s Office of Scientific Operations has been recognized with a 2020 NCI Director’s Award. The award, from the “Making an Impact” category, recognizes the team’s work to establish the annual Technology Showcase, an event that fosters scientific collaboration as well as licensing of NCI technologies.

2019 Technology Showcase Highlights Technologies, Partnerships—and Frederick

Frederick has become a key player in biomedical research. That was the clear message from the third annual Technology Showcase, hosted by the National Cancer Institute and the Frederick National Laboratory for Cancer Research. As usual, the event highlighted the numerous technologies developed by NCI and FNL scientists that are available to external groups for licensing and partnership. But this year, it also showcased the strength of the region.

Annual Event Connects NCI and FNL Technologies with Potential Partners

Next month, the annual Technology Showcase will return to the Frederick National Laboratory for Cancer Research. The event attracts research innovators and business professionals who wish to learn about advanced technologies being developed at the National Cancer Institute and Frederick National Laboratory.